{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T00:45:43Z","timestamp":1774658743864,"version":"3.50.1"},"reference-count":75,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2025,2,2]],"date-time":"2025-02-02T00:00:00Z","timestamp":1738454400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Jiangxi Provincial Natural Science Foundation","award":["20242BAB25355"],"award-info":[{"award-number":["20242BAB25355"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pathogens"],"abstract":"<jats:p>Merkel cell polyomavirus (MCV) was named for its role as the causative agent of Merkel cell carcinoma (MCC), which is MCV positive in approximately 80% of cases. MCV is classified as a Group 2A carcinogen, which promotes carcinogenesis by integrating T-antigen into the cell genome. The prevalence of anti-MCV antibodies in the general population can be as high as 90%. MCV typically promotes cancer by integrating T-antigen genes into the host cell genome, and 80% of MCC cases are attributed to MCV activation. In immunocompetent individuals, MCV usually remains latent after infection. However, the incidence of MCC increases significantly in immunocompromised or immunodeficient patients, such as those who have undergone organ transplantation, have chronic lymphocytic leukemia, or are living with human immunodeficiency virus (HIV) infection. Acquired immunodeficiency is a particular feature of people living with HIV. Currently, research on HIV\/AIDS patients with MCV infection, clinical outcomes, and treatments is quite limited. This paper reviews previous research and systematically examines the relationship between HIV\/AIDS and MCV-associated diseases, with the aim of providing valuable information for the prevention, diagnosis, and treatment of MCV in vulnerable populations.<\/jats:p>","DOI":"10.3390\/pathogens14020134","type":"journal-article","created":{"date-parts":[[2025,2,3]],"date-time":"2025-02-03T04:36:51Z","timestamp":1738557411000},"page":"134","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Merkel Cell Polyomavirus Co-Infection in HIV\/AIDS Individuals: Clinical Diagnosis, Consequences and Treatments"],"prefix":"10.3390","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7756-9460","authenticated-orcid":false,"given":"Xianfeng","family":"Zhou","sequence":"first","affiliation":[{"name":"The Jiangxi Province Key Laboratory for Diagnosis, Treatment and Rehabilitation of Cancer in Chinese Medicine, Cancer Research Center, Jiangxi University of Chinese Medicine, Nanchang 330004, China"},{"name":"Public Health Education and Health Service Center, Jiangxi University of Chinese Medicine, Nanchang 330004, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chenxue","family":"Yin","sequence":"additional","affiliation":[{"name":"Graduate School, Jiangxi University of Chinese Medicine, Nanchang 330004, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ziqi","family":"Lin","sequence":"additional","affiliation":[{"name":"The Jiangxi Province Key Laboratory for Diagnosis, Treatment and Rehabilitation of Cancer in Chinese Medicine, Cancer Research Center, Jiangxi University of Chinese Medicine, Nanchang 330004, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhangren","family":"Yan","sequence":"additional","affiliation":[{"name":"Jiangxi University of Chinese Medicine Affiliated Hospital, Nanchang 330006, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiangang","family":"Wang","sequence":"additional","affiliation":[{"name":"Jiangxi University of Chinese Medicine Affiliated Hospital, Nanchang 330006, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,2,2]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1126\/science.1152586","article-title":"Clonal integration of a polyomavirus in human Merkel cell carcinoma","volume":"319","author":"Feng","year":"2008","journal-title":"Science"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.abd.2022.09.003","article-title":"Merkel cell carcinoma: Epidemiology, clinical features, diagnosis and treatment of a rare disease","volume":"98","author":"Siqueira","year":"2023","journal-title":"An. Bras. Dermatol."},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Zhou, X., Zhu, C., and Li, H. (2023). BK polyomavirus: Latency, reactivation, diseases and tumorigenesis. Front. Cell. Infect. Microbiol., 13.","DOI":"10.3389\/fcimb.2023.1263983"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1097\/PAS.0000000000001231","article-title":"UV Signature Mutations Reclassify Salivary High-grade Neuroendocrine Carcinomas as Occult Metastatic Cutaneous Merkel Cell Carcinomas","volume":"43","author":"Sun","year":"2019","journal-title":"Am. J. Surg. Pathol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/978-3-030-03502-0_8","article-title":"Merkel Cell Carcinoma in the HIV-1\/AIDS Patient","volume":"Volume 177","author":"Goldstein","year":"2019","journal-title":"HIV\/AIDS-Associated Viral Oncogenesis"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"5009","DOI":"10.1158\/0008-5472.CAN-08-0949","article-title":"Frequent detection of Merkel cell polyomavirus in human Merkel cell carcinomas and identification of a unique deletion in the VP1 gene","volume":"68","author":"Kassem","year":"2008","journal-title":"Cancer Res."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"7064","DOI":"10.1128\/JVI.02400-09","article-title":"Merkel cell polyomavirus-infected Merkel cell carcinoma cells require expression of viral T antigens","volume":"84","author":"Houben","year":"2010","journal-title":"J. Virol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"e02079-16","DOI":"10.1128\/mBio.02079-16","article-title":"Merkel Cell Polyomavirus Exhibits Dominant Control of the Tumor Genome and Transcriptome in Virus-Associated Merkel Cell Carcinoma","volume":"8","author":"Starrett","year":"2017","journal-title":"mBio"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Pham, A.M., Ortiz, L.E., Lukacher, A.E., and Kwun, H.J. (2023). Merkel Cell Polyomavirus Large T Antigen Induces Cellular Senescence for Host Growth Arrest and Viral Genome Persistence through Its Unique Domain. Cells, 12.","DOI":"10.3390\/cells12030380"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Passerini, S., Prezioso, C., Prota, A., Babini, G., Coppola, L., Lodi, A., Epifani, A.C., Sarmati, L., Andreoni, M., and Moens, U. (2022). Detection Analysis and Study of Genomic Region Variability of JCPyV, BKPyV, MCPyV, HPyV6, HPyV7 and QPyV in the Urine and Plasma of HIV-1-Infected Patients. Viruses, 14.","DOI":"10.3390\/v14112544"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1182\/hematology.2021000261","article-title":"How immunodeficiency can lead to malignancy","volume":"2021","author":"Pai","year":"2021","journal-title":"Hematol. Am. Soc. Hematol. Educ. Program."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Prezioso, C., Obregon, F., Ambroselli, D., Petrolo, S., Checconi, P., Rodio, D.M., Coppola, L., Nardi, A., de Vito, C., and Sarmati, L. (2020). Merkel Cell Polyomavirus (MCPyV) in the Context of Immunosuppression: Genetic Analysis of Noncoding Control Region (NCCR) Variability among a HIV-1-Positive Population. Viruses, 12.","DOI":"10.3390\/v12050507"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Houben, R., Celikdemir, B., Kervarrec, T., and Schrama, D. (2023). Merkel Cell Polyomavirus: Infection, Genome, Transcripts and Its Role in Development of Merkel Cell Carcinoma. Cancers, 15.","DOI":"10.3390\/cancers15020444"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Kamminga, S., van der Meijden, E., Feltkamp, M.C.W., and Zaaijer, H.L. (2018). Seroprevalence of fourteen human polyomaviruses determined in blood donors. PLoS ONE, 13.","DOI":"10.1101\/357350"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"3689","DOI":"10.1111\/trf.15557","article-title":"Prevalence of DNA of fourteen human polyomaviruses determined in blood donors","volume":"59","author":"Kamminga","year":"2019","journal-title":"Transfusion"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"DeCaprio, J.A. (2017). Merkel cell polyomavirus and Merkel cell carcinoma. Philos. Trans. R. Soc. B Biol. Sci., 372.","DOI":"10.1098\/rstb.2016.0276"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Rapchak, K., Yagobian, S.D., Moore, J., Khattri, M., and Shuda, M. (2022). Merkel cell polyomavirus small T antigen is a viral transcription activator that is essential for viral genome maintenance. PLoS Pathog., 18.","DOI":"10.1371\/journal.ppat.1011039"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1016\/j.jid.2018.03.1527","article-title":"MCV-miR-M1 Targets the Host-Cell Immune Response Resulting in the Attenuation of Neutrophil Chemotaxis","volume":"138","author":"Akhbari","year":"2018","journal-title":"J. Investig. Dermatol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1146\/annurev-virology-111821-103721","article-title":"Are There More Human Cancer Viruses Left to Be Found?","volume":"11","author":"Moore","year":"2024","journal-title":"Annu. Rev. Virol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1093\/infdis\/jiy070","article-title":"Genetic Variability of the Noncoding Control Region of Cutaneous Merkel Cell Polyomavirus: Identification of Geographically Related Genotypes","volume":"217","author":"Hashida","year":"2018","journal-title":"J. Infect. Dis."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"32956","DOI":"10.18632\/oncotarget.8793","article-title":"RB1 is the crucial target of the Merkel cell polyomavirus Large T antigen in Merkel cell carcinoma cells","volume":"7","author":"Hesbacher","year":"2016","journal-title":"Oncotarget"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"6784","DOI":"10.1038\/onc.2017.277","article-title":"Merkel cell polyomavirus small T antigen induces genome instability by E3 ubiquitin ligase targeting","volume":"36","author":"Kwun","year":"2017","journal-title":"Oncogene"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Cheng, J., Park, D.E., Berrios, C., White, E.A., Arora, R., Yoon, R., Branigan, T., Xiao, T., Westerling, T., and Federation, A. (2017). Merkel cell polyomavirus recruits MYCL to the EP400 complex to promote oncogenesis. PLoS Pathog., 13.","DOI":"10.1371\/journal.ppat.1006668"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"10846","DOI":"10.1128\/JVI.00542-09","article-title":"Regulation of gene expression in primate polyomaviruses","volume":"83","author":"White","year":"2009","journal-title":"J. Virol."},{"key":"ref_25","first-page":"179","article-title":"John Cunningham virus: An overview on biology and disease of the etiological agent of the progressive multifocal leukoencephalopathy","volume":"41","author":"Pietropaolo","year":"2018","journal-title":"New Microbiol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1002\/jmv.21605","article-title":"Functional analysis of polyomavirus BK non-coding control region quasispecies from kidney transplant recipients","volume":"81","author":"Olsen","year":"2009","journal-title":"J. Med. Virol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"10448","DOI":"10.1128\/JVI.00614-10","article-title":"Rearranged JC virus noncoding control regions found in progressive multifocal leukoencephalopathy patient samples increase virus early gene expression and replication rate","volume":"84","author":"Gosert","year":"2010","journal-title":"J. Virol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s12985-018-0939-1","article-title":"COS-7-based model: Methodological approach to study John Cunningham virus replication cycle","volume":"15","author":"Prezioso","year":"2018","journal-title":"Virol. J."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"e2102","DOI":"10.1002\/rmv.2102","article-title":"BK polyomavirus diversity\u2014Why viral variation matters","volume":"30","author":"Blackard","year":"2020","journal-title":"Rev. Med. Virol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"3396","DOI":"10.1128\/JVI.03625-14","article-title":"Sp1 sites in the noncoding control region of BK polyomavirus are key regulators of bidirectional viral early and late gene expression","volume":"89","author":"Bethge","year":"2015","journal-title":"J. Virol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"3144","DOI":"10.1128\/JVI.02916-13","article-title":"High-affinity Rb binding, p53 inhibition, subcellular localization, and transformation by wild-type or tumor-derived shortened Merkel cell polyomavirus large T antigens","volume":"88","author":"Borchert","year":"2014","journal-title":"J. Virol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1128\/CVI.00438-12","article-title":"Age-specific seroprevalences of merkel cell polyomavirus, human polyomaviruses 6, 7, and 9, and trichodysplasia spinulosa-associated polyomavirus","volume":"20","author":"Nicol","year":"2013","journal-title":"Clin. Vaccine Immunol."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"van der Meijden, E., Bialasiewicz, S., Rockett, R.J., Tozer, S.J., Sloots, T.P., and Feltkamp, M.C. (2013). Different serologic behavior of MCPyV, TSPyV, HPyV6, HPyV7 and HPyV9 polyomaviruses found on the skin. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0081078"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"e558s","DOI":"10.6061\/clinics\/2018\/e558s","article-title":"Human polyomaviruses and cancer: An overview","volume":"73","author":"Prado","year":"2018","journal-title":"Clinics"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"112371","DOI":"10.18632\/oncotarget.11222","article-title":"Aberrant expression of miR-21, miR-376c and miR-145 and their target host genes in Merkel cell polyomavirus-positive non-small cell lung cancer","volume":"8","author":"Lasithiotaki","year":"2017","journal-title":"Oncotarget"},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Zhou, X., Nakashima, K., Ito, M., Zhang, X., Sakai, S., Feng, C., Sun, H., Chen, H., Li, T.C., and Suzuki, T. (2020). Prevalence and viral loads of polyomaviruses BKPyV, JCPyV, MCPyV, TSPyV and NJPyV and hepatitis viruses HBV, HCV and HEV in HIV-infected patients in China. Sci. Rep., 10.","DOI":"10.1038\/s41598-020-74244-0"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1002\/cncr.30475","article-title":"Viral oncoprotein antibodies as a marker for recurrence of Merkel cell carcinoma: A prospective validation study","volume":"123","author":"Paulson","year":"2017","journal-title":"Cancer"},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Pastrana, D.V., Tolstov, Y.L., Becker, J.C., Moore, P.S., Chang, Y., and Buck, C.B. (2009). Quantitation of human seroresponsiveness to Merkel cell polyomavirus. PLoS Pathog., 5.","DOI":"10.1371\/journal.ppat.1000578"},{"key":"ref_39","first-page":"e240002","article-title":"NCCN Guidelines\u00ae Insights: Merkel Cell Carcinoma, Version 1.2024","volume":"22","author":"Schmults","year":"2024","journal-title":"J. Natl. Compr. Cancer Netw."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.5858\/2009-0165-RSR2.1","article-title":"Merkel cell carcinoma","volume":"134","author":"Wong","year":"2010","journal-title":"Arch. Pathol. Lab. Med."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"9173","DOI":"10.1128\/JVI.01216-13","article-title":"Merkel cell polyomavirus large T antigen disrupts host genomic integrity and inhibits cellular proliferation","volume":"87","author":"Li","year":"2013","journal-title":"J. Virol."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Haymerle, G., Janik, S., Fochtmann, A., Pammer, J., Schachner, H., Nemec, L., Mildner, M., Houben, R., Grasl, M.C., and Erovic, B.M. (2017). Expression of Merkelcell polyomavirus (MCPyV) large T-antigen in Merkel cell carcinoma lymph node metastases predicts poor outcome. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0180426"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"16272","DOI":"10.1073\/pnas.0806526105","article-title":"T antigen mutations are a human tumor-specific signature for Merkel cell polyomavirus","volume":"105","author":"Shuda","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1177\/09564624221123872","article-title":"HIV-related Merkel cell carcinoma: A report of three cases from the UK","volume":"33","author":"Panou","year":"2022","journal-title":"Int. J. STD AIDS"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.3390\/cancers6031328","article-title":"Merkel cell carcinoma in immunosuppressed patients","volume":"6","author":"Ma","year":"2014","journal-title":"Cancers"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ejca.2016.10.022","article-title":"Merkel cell carcinoma: Epidemiology, prognosis, therapy and unmet medical needs","volume":"71","author":"Schadendorf","year":"2017","journal-title":"Eur. J. Cancer"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.jaad.2007.11.020","article-title":"Clinical characteristics of Merkel cell carcinoma at diagnosis in 195 patients: The AEIOU features","volume":"58","author":"Heath","year":"2008","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/jid.2012.388","article-title":"Systemic immune suppression predicts diminished Merkel cell carcinoma-specific survival independent of stage","volume":"133","author":"Paulson","year":"2013","journal-title":"J. Investig. Dermatol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/417095a","article-title":"HIV preferentially infects HIV-specific CD4+ T cells","volume":"417","author":"Douek","year":"2002","journal-title":"Nature"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"15035","DOI":"10.1038\/nrdp.2015.35","article-title":"HIV infection","volume":"1","author":"Deeks","year":"2015","journal-title":"Nat. Rev. Dis. Primers"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1001\/archdermatol.2011.42","article-title":"Merkel cell polyomavirus infection in HIV-positive men","volume":"147","author":"Wieland","year":"2011","journal-title":"Arch. Dermatol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1097\/CCO.0b013e3283495a5b","article-title":"Merkel cell polyomavirus infection and Merkel cell carcinoma in HIV-positive individuals","volume":"23","author":"Wieland","year":"2011","journal-title":"Curr. Opin. Oncol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/1743-422X-10-84","article-title":"Frequent detection of Merkel cell polyomavirus DNA in sera of HIV-1-positive patients","volume":"10","author":"Fukumoto","year":"2013","journal-title":"Virol. J."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"e29883","DOI":"10.1002\/jmv.29883","article-title":"High rates of anal Merkel Cell Polyomavirus and HPV co-infection among people living with HIV","volume":"96","author":"Passerini","year":"2024","journal-title":"J. Med. Virol."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1093\/aje\/kwv155","article-title":"Seroepidemiology of Human Polyomaviruses in a US Population","volume":"183","author":"Gossai","year":"2016","journal-title":"Am. J. Epidemiol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"2324709619836695","DOI":"10.1177\/2324709619836695","article-title":"An Unusual Presentation of Merkel Cell Carcinoma in a HIV Patient: A Case Report and Literature Review","volume":"7","author":"Ramachandran","year":"2019","journal-title":"J. Investig. Med. High Impact Case Rep."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1159\/000327000","article-title":"Sustained remission of a primary nodal Merkel cell carcinoma in an HIV-positive patient","volume":"34","author":"Brugnaro","year":"2011","journal-title":"Onkologie"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"e594","DOI":"10.1016\/S2352-3026(20)30126-5","article-title":"HIV-associated Burkitt lymphoma","volume":"7","author":"Murphy","year":"2020","journal-title":"Lancet Haematol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41572-019-0060-9","article-title":"Kaposi sarcoma","volume":"5","author":"Cesarman","year":"2019","journal-title":"Nat. Rev. Dis. Prim."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.ejca.2022.03.043","article-title":"Diagnosis and treatment of Merkel cell carcinoma: European consensus-based interdisciplinary guideline\u2014Update 2022","volume":"171","author":"Gauci","year":"2022","journal-title":"Eur. J. Cancer"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1001\/jamadermatol.2023.5362","article-title":"Genetic Risk Factors for Early-Onset Merkel Cell Carcinoma","volume":"160","author":"Mohsin","year":"2024","journal-title":"JAMA Dermatol."},{"key":"ref_62","first-page":"915","article-title":"Merkel cell carcinoma: A clinicopathological study of 10 cases","volume":"50","author":"Luo","year":"2021","journal-title":"Zhonghua Bing Li Xue Za Zhi"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1097\/DAD.0000000000002457","article-title":"Merkel Cell Hyperplasia Versus Intraepidermal Merkel Cell Carcinoma: A Comparative Study of 2 Cases","volume":"45","author":"Valiga","year":"2023","journal-title":"Am. J. Dermatopathol."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"742","DOI":"10.6004\/jnccn.2018.0055","article-title":"Merkel Cell Carcinoma, Version 1.2018, NCCN Clinical Practice Guidelines in Oncology","volume":"16","author":"Bichakjian","year":"2018","journal-title":"J. Natl. Compr. Cancer Netw."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s13073-020-00727-4","article-title":"Clinical and molecular characterization of virus-positive and virus-negative Merkel cell carcinoma","volume":"12","author":"Starrett","year":"2020","journal-title":"Genome Med."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1038\/modpathol.2015.154","article-title":"Next generation sequencing of Cytokeratin 20-negative Merkel cell carcinoma reveals ultraviolet-signature mutations and recurrent TP53 and RB1 inactivation","volume":"29","author":"Harms","year":"2016","journal-title":"Mod. Pathol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1056\/NEJMoa1603702","article-title":"PD-1 Blockade with Pembrolizumab in Advanced Merkel-Cell Carcinoma","volume":"374","author":"Nghiem","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1016\/S1470-2045(16)30364-3","article-title":"Avelumab in patients with chemotherapy-refractory metastatic Merkel cell carcinoma: A multicentre, single-group, open-label, phase 2 trial","volume":"17","author":"Kaufman","year":"2016","journal-title":"Lancet Oncol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"eaat2702","DOI":"10.1126\/scitranslmed.aat2702","article-title":"Tuberculosis following PD-1 blockade for cancer immunotherapy","volume":"11","author":"Barber","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jdcr.2020.11.020","article-title":"Immune checkpoint inhibitor therapy in HIV-associated Merkel cell carcinoma: A case series of 3 patients","volume":"8","author":"Park","year":"2021","journal-title":"JAAD Case Rep."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.jaad.2017.12.004","article-title":"Merkel cell carcinoma: An update and review: Current and future therapy","volume":"78","author":"Tello","year":"2018","journal-title":"J. Am. Acad. Dermatol."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"4111","DOI":"10.1200\/JCO.2011.41.4193","article-title":"HIV status does not influence outcome in patients with classical Hodgkin lymphoma treated with chemotherapy using doxorubicin, bleomycin, vinblastine, and dacarbazine in the highly active antiretroviral therapy era","volume":"30","author":"Montoto","year":"2012","journal-title":"J. Clin. Oncol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1182\/asheducation-2013.1.382","article-title":"Update on the treatment of HIV-associated hematologic malignancies","volume":"2013","author":"Little","year":"2013","journal-title":"Hematol. Am. Soc. Hematol. Educ. Program."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1002\/cam4.2781","article-title":"Patterns of distant metastases in 215 Merkel cell carcinoma patients: Implications for prognosis and surveillance","volume":"9","author":"Lewis","year":"2020","journal-title":"Cancer Med."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"421","DOI":"10.32074\/1591-951X-195","article-title":"NeuN, a DNA-binding neuron-specific protein expressed by Merkel cell carcinoma: Analysis of 15 cases","volume":"113","author":"Ungari","year":"2021","journal-title":"Pathologica"}],"container-title":["Pathogens"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-0817\/14\/2\/134\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T16:25:45Z","timestamp":1760027145000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-0817\/14\/2\/134"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,2]]},"references-count":75,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,2]]}},"alternative-id":["pathogens14020134"],"URL":"https:\/\/doi.org\/10.3390\/pathogens14020134","relation":{},"ISSN":["2076-0817"],"issn-type":[{"value":"2076-0817","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,2]]}}}